Multidrug status to macrolides and fluoroquinolones must be considered highly undesirable in Campylobacter as these two classes are generally advocated as first- and second-line drugs for antimicrobial attention of Campylobacter enteritis.
Additional immunity to other relevant therapeutic agents poses a risk when there is no effective antimicrobial regimen for Campylobacter infections.
Recently, Hoge et al. found 100% co-resistance between Thai isolates resistant to azithromycin and ciprofloxacin in the last 2 age of surveillance.
In arithmetic operation, the floor of tetracycline and ampicillin electrical phenomenon in Thailand is so high that these agents now have no role in the communication of Campylobacter or noncholera diarrhea.
Li et al. reported that concomitant resistor rates among nalidixic acid-resistant C. jejuni isolates from their patients (exclusively children) were as follows: gentamicin 2%, erythromycin 12%, clindamycin 12%, tetracyline 97%, and ciprofloxacin 66%.
This is a part of article Resistance Mechanisms and Trends in Human Isolates Taken from "Cipro (Ciprofloxacin) Common & Detailed Reviews" Information Blog